Headline: CME Group (NASDAQ:CME) Q4 CY2025 Revenue Meets Expectations - $1.65B, EPS $2.77

[Para 1: The Lead] CME Group, a leading financial derivatives exchange, reported Q4 CY2025 revenue of $1.65 billion, an 8.1% year-over-year increase, matching Wall Street forecasts. The company's non-GAAP earnings per share of $2.77 surpassed analyst consensus by 1%, showcasing solid financial performance. [Para 2-3: Supporting details & Context] CME Group's revenue growth is attributed to strong performance in its key segments, including clearing and settlement services, and market data. The company's non-GAAP profit of $2.77 per share reflects its operational efficiency and market leadership. CME Group's growth, while positive, is within the context of a historically tepid 6% compounded annual growth rate over the past five years. However, the 8.1% annualized revenue growth over the last two years signals a potential upward trend. Investors should consider CME Group's valuation, business qualities, and recent quarter's performance in their investment decisions.